Leukaemia Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with Acute Myeloid Leukaemia (AML) confirmed through blood or bone marrow testing
- People who have been newly diagnosed and are being considered for a new course of treatment
- People who are 50 years of age or older
- People who have a relatively good level of physical functioning (rated on a standard medical scale as largely independent or better — confirm with trial site)
Who may not be able to join:
- People who are unable to understand or sign a written consent form agreeing to take part in the trial
- People who are unable to complete questionnaires on their own and do not have someone available to help them do so
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Catherine Lai, MD, Abramson Cancer Center at Penn Medicine
Phone: 2152209693
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Evaluate physiologic age using baseline measures of physical function, depression, cognition, frailty, and PROs in newly diagnosed AML patients receiving intensive and non-intensive treatment in relation to overall survival at 1 year.; Evaluate baseline measures of physiologic age in relation to short term mortality; Evaluate baseline measures of physiologic age in relation to grade 3, 4, and 5 toxicities from treatment; Evaluate baseline measures of physiologic age in relation to complete remission; Compare baseline measurements to serial measurements to understand how physical function chang...
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.